Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results

Core Viewpoint - Optinose will report its financial results for Q4 and the full year of 2024 on March 20, 2025, before market open [1] Group 1: Financial Results Announcement - The company will provide financial results for the fourth quarter and full year of 2024 [1] - A conference call will be held to discuss these results and corporate updates [2] Group 2: Conference Call Details - The conference call is scheduled for March 20, 2025, at 8:00 a.m. Eastern Time [2] - Participants can access the call via webcast or telephone, with registration required for telephone participation [3] Group 3: Company Overview - Optinose is a specialty pharmaceutical company focused on patients treated by ENT and allergy specialists [4]